Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP899505.RAXtVVG0rqrrCFL0u0QZfM_jsNXdDfBS3Zw69_virjAtY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP899505.RAXtVVG0rqrrCFL0u0QZfM_jsNXdDfBS3Zw69_virjAtY130_assertion type Assertion NP899505.RAXtVVG0rqrrCFL0u0QZfM_jsNXdDfBS3Zw69_virjAtY130_head.
- NP899505.RAXtVVG0rqrrCFL0u0QZfM_jsNXdDfBS3Zw69_virjAtY130_assertion description "[Clinical association studies consistently revealed that low levels of Hsp60 or GANAB and high levels of Gp96 or Grp78 are significantly associated with advanced cancer (P < 0.001 to P = 0.047, respectively, for the four molecules) and poor survival (P < 0.001 to P = 0.025, respectively, for the four molecules).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP899505.RAXtVVG0rqrrCFL0u0QZfM_jsNXdDfBS3Zw69_virjAtY130_provenance.
- NP899505.RAXtVVG0rqrrCFL0u0QZfM_jsNXdDfBS3Zw69_virjAtY130_assertion evidence source_evidence_literature NP899505.RAXtVVG0rqrrCFL0u0QZfM_jsNXdDfBS3Zw69_virjAtY130_provenance.
- NP899505.RAXtVVG0rqrrCFL0u0QZfM_jsNXdDfBS3Zw69_virjAtY130_assertion SIO_000772 21642380 NP899505.RAXtVVG0rqrrCFL0u0QZfM_jsNXdDfBS3Zw69_virjAtY130_provenance.
- NP899505.RAXtVVG0rqrrCFL0u0QZfM_jsNXdDfBS3Zw69_virjAtY130_assertion wasDerivedFrom befree-2016 NP899505.RAXtVVG0rqrrCFL0u0QZfM_jsNXdDfBS3Zw69_virjAtY130_provenance.
- NP899505.RAXtVVG0rqrrCFL0u0QZfM_jsNXdDfBS3Zw69_virjAtY130_assertion wasGeneratedBy ECO_0000203 NP899505.RAXtVVG0rqrrCFL0u0QZfM_jsNXdDfBS3Zw69_virjAtY130_provenance.